Apotex offers a variety of products to our International partners. Most products are in oral dosage forms — tablets and capsules. Our facilities are EMEA approved and we have experience with registrations in most European countries. We have flexible terms and you can count on our facilities in Canada or India to meet your customer product needs.
We are continuously investing in R&D, ensuring a long future for Apotex and our partners. One of our core strengths lies with our vertical integration from formulation, API development, product development, and manufacturing.
Currently, we sell to over 115 countries and we aim to be competitive in the timing of our launches for our pipeline products. Our goal is to increase our presence throughout Europe by licensing to strategic partners and supplying high quality product.
For a complete list of our products available for licensing to Europe please submit your opportunity for our consideration.